Trust and AI Adoption in Medicine

The challenge isn’t whether AI can be used (it already is). It’s whether it can be trusted. And trust in medicine is not something healthcare professionals can afford to get wrong.  The post Trust and AI Adoption in Medicine appeared first on MedCity News.

Read More

Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs

Kailera Therapeutics’ IPO proceeds will support global clinical trials for its obesity drug candidates. Meanwhile, proteomics company Alamar Biosciences upsized its own IPO while clinical-stage biotechs Seaport Therapeutics and Hemab Therapeutics joined the IPO queue. The post Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs appeared first on MedCity…

Read More